Fludarabine plus cyclophosphamide (FC) in patients with previously untreated low-grade lymphoma

被引：0
|
作者：
Dell'Olio, M. [1 ]
La Sala, A. [1 ]
Merla, E. [1 ]
Bodenizza, C. [1 ]
Carella, A. M. [1 ]
Falcone, A. [1 ]
Greco, M. M. [1 ]
Mantuano, S. [1 ]
Melillo, L. [1 ]
Nobile, M. [1 ]
Sanpaolo, G. [1 ]
Scalzulli, P. R. [1 ]
Cascavilla, N. [1 ]
机构：
[1] Casa Sollievo Sofferenza Hosp, IRCCS, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：186 / 186
页数：1
相关论文
共 50 条
  • [31] HIGH-ACTIVITY OF MITOXANTRONE IN PREVIOUSLY UNTREATED LOW-GRADE LYMPHOMAS
    HANSEN, SW
    NISSEN, NI
    HANSEN, MM
    HOUJENSEN, K
    PEDERSENBJERGAARD, J
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 22 (01) : 77 - 79
  • [32] Fludarabine versus cyclophosphamide, vincristine, and prednisone in recurrent low-grade lymphomas - In reply
    Klasa, RJ
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (13) : 2626 - 2627
  • [33] UNTREATED LOW-GRADE NON-HODGKINS LYMPHOMA - REPLY
    GAYNOR, ER
    ULTMANN, JE
    NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (18): : 1191 - 1192
  • [34] FLUDARABINE PHOSPHATE - A NEW AGENT WITH MAJOR ACTIVITY IN LOW-GRADE LYMPHOMA
    REDMAN, J
    CABANILLAS, F
    MCLAUGHLIN, P
    HAGEMEISTER, F
    VELASQUEZ, W
    SWAN, F
    RODRIGUEZ, M
    PLUNKETT, W
    KEATING, M
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 211 - 211
  • [35] Safety and Efficacy of Obinutuzumab Plus Fludarabine and Cyclophosphamide in Previously Untreated Patients with Chronic Lymphocytic Leukemia: Subgroup Analysis of the GREEN Study
    Leblond, Veronique
    Cantin, Guy
    Cortelezzi, Agostino
    Knauf, Wolfgang
    Tiab, Mourad
    Turgut, Mehmet
    Zaritskey, Andrey
    Merot, Jean-Louis
    Trunzer, Kerstin
    Robson, Susan
    Gresko, Ekaterina
    Stilgenbauer, Stephan
    Foa, Robin
    Bosch, Francesc
    BLOOD, 2017, 130
  • [36] Chemoimmunotherapy With Low-Dose Fludarabine and Cyclophosphamide and High Dose Rituximab in Previously Untreated Patients With Chronic Lymphocytic Leukemia
    Foon, Kenneth A.
    Boyiadzis, Michael
    Land, Stephanie R.
    Marks, Stanley
    Raptis, Anastasios
    Pietragallo, Louis
    Meisner, Dennis
    Laman, Andrew
    Sulecki, Mathew
    Butchko, Allyson
    Schaefer, Patricia
    Lenzer, Diana
    Tarhini, Ahmad
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) : 498 - 503
  • [37] Phase III trial of fludarabine plus cyclophosphamide compared with fludarabine for patients with previously untreated chronic lymphocytic leukemia: US Intergroup Trial E2997
    Flinn, Ian W.
    Neuberg, Donna S.
    Grever, Michael R.
    Dewald, Gordon W.
    Bennett, John M.
    Paietta, Elisabeth M.
    Hussein, Mohamad A.
    Appelbaum, Frederick R.
    Larson, Richard A.
    Moore, Dennis F., Jr.
    Tallman, Martin S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) : 793 - 798
  • [38] A Phase II Trial of Bendamustine, Bortezomib, and Rituximab in Patients with Previously Untreated Low Grade Lymphoma
    Flinn, Ian W.
    Ervin, Thomas J.
    Boccia, Ralph V.
    Flora, Douglas B.
    Cuevas, J. Daniel
    Thompson, Dana S.
    Shipley, Dianna L.
    Berdeja, Jesus G.
    BLOOD, 2015, 126 (23)
  • [39] High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone (FCM) in previously untreated patients with advance stage follicular lymphoma (FL)
    Montoto, S
    López-Guillermo, A
    Domingo-Doménech, E
    Ribera, J
    Estany, C
    Altés, A
    Besalduch, J
    Pedro, C
    Gardella, S
    Escoda, L
    Asensio, A
    Vivancos, P
    Galán, P
    Bosch, F
    Moreno, C
    de Sevilla, AF
    Montserrat, E
    ANNALS OF ONCOLOGY, 2005, 16 : 152 - 153
  • [40] High clinical and molecular response rates with fludarabine, cyclophosphamide and mitoxantrone (FCM) in previously untreated patients with advanced stage follicular lymphoma (FL).
    Montoto, S
    Lopez-Guillermo, A
    Domingo-Domenech, E
    Ribera, JM
    Altes, A
    Estany, C
    Besalduch, J
    Escoda, L
    Pedro, C
    Gardella, S
    Asensio, A
    Fernandez de Sevilla, A
    Dolors, C
    Carolina, M
    Montserrat, E
    BLOOD, 2003, 102 (11) : 401A - 401A
12345